Daiichi Sankyo Nears Final Trials For Japan's First Four-In-One Vaccine
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo is zeroing in on developing Japan's first vaccine that protects against four diseases and not just against the usual three